|
Status |
Public on Jun 12, 2022 |
Title |
Dynamic IFNβ signalling underlies treatment response to immune checkpoint therapy in cancer [single-cell RNA-seq] |
Organism |
Mus musculus |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
The on/off dynamics of IFNβ signalling underlie the therapeutic response to immune checkpoint therapy in cancer, which can be identified in Ly6C+ monocytes
|
|
|
Overall design |
12 samples, 6 across AB1 and 6 across Renca models
|
|
|
Contributor(s) |
Zemek R, Lesterhuis WJ |
Citation(s) |
35986006 |
BioProject |
PRJNA643595 |
|
Submission date |
Jul 07, 2020 |
Last update date |
Aug 31, 2022 |
Contact name |
Wee Loong Chin |
Organization name |
National Centre For Asbestos Related Diseases
|
Street address |
Level 5, Qq Block, Qeii Medical Centre 6 Verdun St, Nedlands
|
City |
Perth |
ZIP/Postal code |
6009 |
Country |
Australia |
|
|
Platforms (1) |
GPL13112 |
Illumina HiSeq 2000 (Mus musculus) |
|
Samples (12)
|
|
This SubSeries is part of SuperSeries: |
GSE153943 |
Dynamic IFNβ signalling underlies treatment response to immune checkpoint therapy in cancer |
|
Relations |
SRA |
SRP271726 |